Spots Global Cancer Trial Database for microvascular invasion
Every month we try and update this database with for microvascular invasion cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Artificial Intelligence and Hepatocellular Carcinoma | NCT05637788 | HCC | CT Scan Radiomi... | 18 Years - | Humanitas Clinical and Research Center | |
| Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion | NCT06089369 | Hepatocellular ... | Sintilimab (9 c... Sintilimab (18 ... Active surveill... | 18 Years - 75 Years | Tongji Hospital | |
| Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection | NCT02537158 | Hepatocellular ... | Sorafenib TACE | 18 Years - 75 Years | ChineseAMS | |
| Sorafenib Treatment in Patients With Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection | NCT02867280 | Hepatocellular ... Recurrence | Sorafenib | 18 Years - 75 Years | Sun Yat-sen University | |
| Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH | NCT02587884 | Hepatocellular ... | TACE | 18 Years - 70 Years | Eastern Hepatobiliary Surgery Hospital | |
| Vascular Invasion Signatures in cfDNA Support Re-staging of Liver Cancer | NCT05540925 | Carcinoma, Hepa... Hepatocellular ... Liver Cancer | Liver resection | 25 Years - 75 Years | Eastern Hepatobiliary Surgery Hospital | |
| Preoperative Estimation of Microvascular Invasion in Hepatocellular Carcinoma | NCT03110068 | Hepatocellular ... | contrast-enhanc... contrast-enhanc... | 18 Years - 80 Years | Sun Yat-sen University | |
| A Study of Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver Cancer | NCT05371873 | Hepatocellular ... | Liver resection... | 18 Years - 80 Years | First Affiliated Hospital of Zhejiang University | |
| Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection | NCT02537158 | Hepatocellular ... | Sorafenib TACE | 18 Years - 75 Years | ChineseAMS | |
| Sorafenib Treatment in Patients With Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection | NCT02867280 | Hepatocellular ... Recurrence | Sorafenib | 18 Years - 75 Years | Sun Yat-sen University | |
| Vascular Invasion Signatures in cfDNA Support Re-staging of Liver Cancer | NCT05540925 | Carcinoma, Hepa... Hepatocellular ... Liver Cancer | Liver resection | 25 Years - 75 Years | Eastern Hepatobiliary Surgery Hospital | |
| Non-invasive Prediction of Microvascular Invasion in Hepatocellular Carcinoma by Blood-Oxygen-Level Dependent Magnetic Resonance Imaging (BOLD MRI) | NCT00963612 | Hepatocellular ... | BOLD MRI test | 18 Years - | University Health Network, Toronto | |
| Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma Patients | NCT02523053 | Hepatocellular ... Recurrence | Hepatectomy 5-Fluorouracil | 18 Years - 70 Years | Eastern Hepatobiliary Surgery Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
